Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: TAP Pharmaceutical Products, Inc.
Current Parent Company:
Takeda Pharmaceutical
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $525,780
Year: 2001
Date: December 19, 2001
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: TAP Pharmaceutical Products, Inc. agreed to pay $525,780 to settle charges of illegal marketing practices for the drug Lupron.
Level of Government: state
Action Type: agency action
Agency: Arkansas Attorney General
Civil or Criminal Case: civil
Facility State: Arkansas
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Source Notes: If an online information source is not working, check the Violation Tracker
Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
